InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
4
Disclosed sells
0
T+90 hit rate
59%
T+90 mean return
+1.7%
Across 29 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Fernandez Henry A, Chairman & CEO. Director active across 2 companies, notably Royalty Pharma plc. Aggregated, 43 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €1.9m. Activity tracked since 25 June 2021. The latest transaction was disclosed on 13 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations43 total
7,614 shares0Class A Ordinary SharesSEC:0001802768-25-000051:0
1,141 shares@ US$32.86582.0% of flowClass A Ordinary SharesSEC:0001802768-25-000016:0
500 shares@ US$569.8632.6% of flowCommon StockSEC:0001408198-25-000066:0
Ideal exit: 21 Nov 2025 (T+270)
58,370 shares0Common StockSEC:0001408198-25-000060:0
1,503 shares@ US$24.94162.1% of flowClass A Ordinary SharesSEC:0001802768-25-000005:0
600 shares@ US$610.0041.7% of flowCommon StockSEC:0001408198-24-000184:0
Ideal exit: 1 Sept 2025 (T+270)
1,342 shares@ US$27.92491.9% of flowClass A Ordinary SharesSEC:0001802768-24-000054:0
1,399 shares@ US$26.79982.0% of flowClass A Ordinary SharesSEC:0001802768-24-000042:0
9,293 shares0Class A Ordinary SharesSEC:0001802768-24-000031:0
500 shares@ US$459.4825.7% of flowCommon StockSEC:0001408198-24-000081:0
Ideal exit: 20 Jan 2025 (T+270)
1,240 shares@ US$30.22832.0% of flowClass A Ordinary SharesSEC:0001802768-24-000018:0
84,022 shares0Common StockSEC:0001408198-24-000027:0
1,353 shares@ US$27.7112.0% of flowClass A Ordinary SharesSEC:0001802768-23-000036:0
1,384 shares@ US$27.07752.1% of flowClass A Ordinary SharesSEC:0001209191-23-051475:0
1,208 shares@ US$31.02732.0% of flowClass A Ordinary SharesSEC:0001209191-23-040238:0
7,747 shares0Class A Ordinary SharesSEC:0001209191-23-039682:0
1,049 shares@ US$35.72762.0% of flowClass A Ordinary SharesSEC:0001209191-23-021883:0
28,472 shares0Common StockSEC:0001209191-23-008419:0
943 shares@ US$39.76132.0% of flowClass A Ordinary SharesSEC:0001209191-23-000324:0
913 shares@ US$41.06292.2% of flowClass A Ordinary SharesSEC:0001209191-22-051640:0
903 shares@ US$41.52030.0001% mcap2.7% of flowClass A Ordinary SharesSEC:0001209191-22-039876:0
6,328 shares0Class A Ordinary SharesSEC:0000899243-22-024032:0
964 shares@ US$38.87030.0001% mcap2.5% of flowClass A Ordinary SharesSEC:0001209191-22-022058:0
32,500 shares@ US$37.48840.0035% mcap80.3% of flowClass A Ordinary SharesSEC:0001209191-22-013383:0
Ideal exit: 21 Nov 2022 (T+270)
4,275 shares0Common StockSEC:0001209191-22-008021:0
25 of 43 declarations
About Fernandez Henry A
Henry A. Fernandez is a Board Member and Chairman and CEO at Royalty Pharma plc and MSCI Inc. He plays a key role in governance and strategic direction of these companies. His experience is valuable in guiding initiatives and ensuring growth.
